Immune Checkpoint Inhibitor Therapy Toxicities
JAMA
.
2021 Jul 6;326(1):87.
doi: 10.1001/jama.2021.6030.
Authors
Heather S L Jim
1
,
Hans Knoop
2
,
Adam P Dicker
3
Affiliations
1
Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, Florida.
2
Department of Medical Psychology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
3
Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
PMID:
34228072
DOI:
10.1001/jama.2021.6030
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Immune Checkpoint Inhibitors*
Neoplasms* / drug therapy
Substances
Immune Checkpoint Inhibitors